FTRE
Fortrea Holdings Inc.NASDAQHealthcare$9.45-0.63%ClosedMarket Cap: $883.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.53
P/S
0.32
EV/EBITDA
-0.95
DCF Value
$-4.61
FCF Yield
10.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
16.4%
Operating Margin
-19.8%
Net Margin
-36.2%
ROE
-152.2%
ROA
-87.0%
ROIC
-29.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $660.5M | 16.9% | $8.8M | $-32.5M | $-0.36 | — |
| FY 2025 | $2.72B | 15.6% | $-30.6M | $-986.2M | $-10.81 | — |
| Q3 2025 | $701.3M | 14.7% | $-15.9M | $-15.9M | $-0.17 | — |
| Q2 2025 | $710.3M | 16.0% | $-10.9M | $-374.9M | $-4.14 | — |
| Q1 2025 | $651.3M | 17.9% | $-520.1M | $-562.9M | $-6.30 | — |
| Q4 2024 | $697.0M | 20.2% | $-55.6M | $-61.2M | $-0.68 | — |
| FY 2024 | $2.70B | 19.8% | $-161.9M | $-328.5M | $-3.67 | — |
| Q3 2024 | $674.9M | 22.0% | $-18.0M | $-27.9M | $-0.31 | — |
| Q2 2024 | $662.4M | 20.7% | $-50.9M | $-138.4M | $-1.55 | — |
| Q1 2024 | $662.1M | 16.3% | $-37.4M | $-101.0M | $-1.15 | — |
| Q4 2023 | $775.4M | 15.4% | $-10.7M | $-36.0M | $-0.41 | — |
| FY 2023 | $2.84B | 20.8% | $32.0M | $-25.2M | $-0.04 | — |